Proteus Digital Health, which is backed by Medtronic, Novartis and others, raises more than $172 million in a Series G funding round in support of its sensor-embedded ingestible pills.
California-based Proteus Digital Health closed a Series G funding round this week with more than $172 million pledged in support of the company's ingestible sensor-laden pills.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mZL9ha
Cap comentari:
Publica un comentari a l'entrada